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Comparison of home hemodialysis to continuous ambulatory peritoneal
dialysis. We evaluated prospectively various outcome measurements of
patients assigned initially to continuous ambulatory peritoneal dialysis
(CAPD) and home hemodialysis (HHD) from February 1979 to August
1981 and the causes for failures of the techniques. Morbidity was
assessed by time in hospital/time on dialysis. Fifty-six patients were
trained for CAPD and 37 for HHD. Those assigned to CAPD experi-
enced an increased frequency of hospitalization (7.5% CAPD, 2.8%
HHD, respectively) primarily due to episodes of peritonitis. There was
also a higher modality failure rate (43% vs. 16%). However, the groups
were not comparable in all respects. For example, the CAPD popula-
tion included 21 patients with major cardiovascular diseases versus only
three in the HHD group. The demographic characteristics of both
populations including race, sex, age, income, place of residence,
marital status, and education were similar. At the time of this study
there is no direct evidence showing that healthy patients otherwise able
to perform HHD may be maintained with less morbidity for a prolonged
period utilizing CAPD. Therefore, we suggest that HHD is the home
method of choice for patients able to proceed with this technique.
CAPD may be indicated for patients in whom the period of home
dialysis is expected to be relatively short and who would be otherwise
unable to carry out home dialysis, for example, patients awaiting
transplantation and those unable to be maintained on hemodialysis
because of impaired cardiac function. To fully evaluate CAPD as along-
term maintenance therapy, a prospective trial must be performed.
Comparaison de Ia dialyse a domicile a Ia dialyse péritonéale continue
ambulatoire. Nous avons évalué prospectivement diverses mesures du
devenir de malades mis initialement en dialyse péritonéale continue
ambulatoire (CAPD) ou en dialyse a domicile (HHD) du 1979 février au
1981 aoUt, et les raisons des échecs de ces techniques. La morbidité a
été mesurée par le temp a l'hôpital/temp en dialyse. Cinquante-six
malades ont été entrainés pour Ia CAPD, trente-sept pour I'HHPD.
Ceux mis en CAPD ont eu une augmentation accrue de fréquence
d'hospitalisation (7,5% CAPD, 2,8% HHD, respectivement) essentielle-
ment due a des episodes de péritonite. Ii y avait egalement un taux
d'échec superieur (43% contre 16%). Cependant les groupes n'étaient
pas comparables sur tous les plans. Par exemple, la population de
CAPD comprenait 21 malades avec des maladies cardiovasculaires
graves, contre seulement trois dans le groupe HHD. Les caractéris-
tiques demographiques de population, notamment la race, le sexe,
l'age, le revenu, le lieu de residence, l'état marital, et l'dducation
étaient identiques. Pour l'instant il n'y a pas de preuve directe indiquant
que les sujets en bonne sante qui seraient autrement capables d'être en
HHD pourraient être maintenus avec une plus faible morbidité pendant
une periode prolongee en CAPD. C'est pourquoi nous suggérons que
l'HHD est Ia méthode de choix a domicile pour les malades capables de
suivre cette technique. La CAPD pourrait être indiquee chez les
malades chez qui la durée de dialyse a domicile risque d'être relative-
ment courte, et qui pourraient être incapables d'entreprendre Ia dialyse
a domicile, par exemple les malades en attente de transplantation, et les
malades ne pouvant être maintenus en hemodialyse en raison d'une
alteration de Ia fonction cardiaque. Afin d'évaluer l'intérCt de Ia CAPD
comme un traitement d'entretien a long terme, une étude prospective
randomisée doit être entreprise.
Continuous ambulatory peritoneal dialysis (CAPD) was ad-
vocated as a home dialysis technique in 1978 [II. It is not yet
known which patients are best suited to undertake this therapy
nor are long-term survival studies available. The issue is not
whether a patient undergoing CAPD may be managed at home
but whether this technique maintains patients as effectively as
home hemodialysis (HHD). To determine which patients may
be better suited to be treated by CAPD or HHD and to ascertain
if CAPD is at least as effective in managing patients requiring
maintenance dialysis, we initiated, though nonrandomized, a
prospective study. The population included all patients who
entered home dialysis at the University of Mississippi (either
CAPD or HHD) from February 1979 to August 1981 and who
were managed by the authors.
To evaluate the success of the respective therapies, we
compared the morbidity associated with each technique. To
determine if we were treating similar populations, we reviewed
the cause of renal failure and the reason for undertaking home
dialysis, medical status, certain demographic features (race,
age, sex, income, place of residence, total education in years,
and marital status) and one measure of infirmity — the ability of
the patients to puncture their own vascular access or bag. We
also attempted to find demographic risk factors associated with
enhanced morbidity with CAPD. Finally, we evaluated the
chemistries of the patients over a period of time on dialysis, and
the mean blood pressure control.
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Methods
Definitions. The cause of the patients' renal failure was
ascribed to either glomerulonephritis, chronic interstitial ne-
phritis, hypertensive nephrosclerosis, polycystic kidney dis-
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ease, or diabetes mellitus on the basis of clinical criteria and
where possible, renal biopsy. If we could not ascertain a
conclusive etiotogic diagnosis, we classified a patient as having
no diagnosis. We analyzed a separate outcome of 21 patients
who were assigned to CAPD because of frequent hypotensive
episodes while undergoing hemodialysis, severe angina on
dialysis, or congestive heart failure unresponsive to ultrafiltra-
tion during hemodialysis because of hypotension,
Patient income was determined by patient interview at the
initial social evaluation and grouped into those earning less than
$10,000 at the start of home dialysis (including welfare income)
and more than $10,000. Marital status was grouped into patients
married (including common law) or not married. Place of
residence was defined as urban if the patient lived in a commu-
nity with greater than 2,500 people or rural. The reason for
undertaking home dialysis was defined as either patient choice
or physician allocation to therapy.
Patients undergoing HHD were dialyzed using a I m2, 11.5 s
membrane dialyzer (Gambro Lundia. AB Gambro, Lund. Swe-
den) 4 to 5 hr three times per week. Blood flow was at least 200
mi/mm. Dialysate was delivered at flow rates of 500 mI/mm
using Eri-lyte 8113 heniodialysis concentrate (Erika Inc, Rock-
leigh, New Jersey) and a Cohe Centry II proportioning system
(Cobe Laboratories Inc., Lakewood, Connecticut). The con-
centrate delivers, after dilution (1/34). sodium 132 mEq/liter,
potassium 2 mEq/liter, calcium 3.5 mEq/Iiter, magnesium 1.5
mEq/liter, acetate 35 mEq/litcr, and chloride 104 mEq/liler.
CAPD was performed using techniques as described by
Oreopoulos [2]. All patients were maintained on four exchanges
of dialysate 7 days per week except for one patient who was
maintained on three exchanges daily and two on five exchanges
per day. Dialysate was manufactured by Travenol Laboratories
(Deerfield, Illinois). The dialysate contained either 4.25%,
2.5%, or 1.5% glucose and the following electrolytes: sodium
132 mEq/liter, calcium 3.5 mEq/liter, magnesium 1.5 mEq/liter,
chloride 102 mEq/liter, and lactate 35 mEq/liter.
Peritonitis was diagnosed when a patient was admitted to the
hospital with a clinical episode of cloudy dialysate and abdomi-
nal pain. We also included episodes of turbid dialysate wherein
the patients were managed at home when turbid dialysate
persisted for at least I day whether or not cultures of dialysate
yielded organisms. Access infection was diagnosed when a
patient developed signs of inflammation, including redness,
heat, or purulent drainage from an access site.
We defined morbidity as time in the hospital versus time on
home dialysis. We analyzed separately dialysis-related morbid-
ity which was caused by modality-related infection (peritonitis
in the case of CAPD and access infection in the case of HHD).
Therefore, the infection rate was defined as the number of
episodes per patient of either peritonitis or access infection(s)
per patient to time on home dialysis.
Body surface area was calculated by using the patient's initial
weight at the start of home dialysis [31. The patient's weight was
obtained at the clinic. Each patient was fully clothed but
without shoes. Patients undergoing CAPD were weighed after
dialysate drainage.
The chemistry of the serum concentrations was measured
either at the University of Mississippi central pathology labora-
tories or at Puckett Laboratories in Hattiesburg, Mississippi,
using autoanalyzer techniques. A 24-hr measurement of creati-
nine clearance was determined within 3 months of beginning
home dialysis [41.
Data analysis. To illustrate the ability to maintain a patient
on a dialysis technique, we calculated maintenance curves for
each dialysis technique by the method of Kaplan and Meier [5].
These curves are similar to survival curves hut the endpoint is
withdrawal from dialysis as well as death of the patient. In these
analyses withdrawals due to transplantation, transfer to another
facility, or return of renal function were treated as censored
data. Censored data does not contribute to a decrement in the
maintenance slope.
The calculation of the group average morbidity, that is,
morbidity due to infection and infection rate, may differ from
the calculation of overall morbidity obtained by using the total
time in the hospital divided by the total time on dialysis. It is
possible to spend 20 of 40 total days in the hospital, a morbidity
of 0.5, and have another patient with 20 out of 100 days for a
morbidity of 0.2. The average morbidity is 0.35. the total
morbidity 40 out of 140 is 0.285.
We tested for differences between groups of patients by x2
(demographic characteristics), analysis of variance, or Stu-
dent's (test where appropriate. Significance was accepted at a
P value of less than 0.05.
Because patients undergoing CAPD manifest a relatively
stable serum chemistry and weight, whereas patients undergo-
ing HHD do not, we chose a method of trend analysis of serum
chemistries over time to evaluate patients within each group
and between groups. This was done by determining the linear
regression of each patient's serum value and weight against the
day interval from the start of home dialysis. The slopes of these
individual regressions were then averaged. An overall t statistic
with N— I degrees of freedom for the slope was then derived by
dividing the mean slope, by the SEM of the mean slope. This
assesses whether or not the group slope is significantly different
from 0 (no slope) [6, 71. The mean slopes for each group for the
various parameters were tested to determine if there was a
significant slope (or trend over time on dialysis) and for
differences between each group by Student's t test. Further-
more, we obtained one mean value for each patient and then
derived the overall group mean value. We tested for differences
between the overall mean values using Student's t test. Signifi-
cance was accepted at a P value of less than 0.05.
Results
There were 56 patients entered into CAPD during this time
period and 37 into home hemodialysis. Table I provides select-
ed demographic information for patients undergoing HHD or
CAPD. There is a high withdrawal rate among CAPD patients
(P < 0.01, 2 = 6.87). There were no differences in the
demographic features of each group. Although there were more
diabetic patients in the CAPD group and fewer patients with
polycystic kidney disease, we did not demonstrate enhanced
morbidity related to a particular etiologic diagnosis of uremia
among each treatment group.
The probability of remaining in the therapy to which our
patients were assigned originally is represented by actuarial
analysis (maintenance curve, Fig. 1). Most of the patients who
did not remain on CAPD dropped out by about 240 days, the
time corresponding to the average duration of CAPD for
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HHD
(N=37)
CAPD
(N=56)
Age, years 42.0 2.2a 47.0 2.2
Race
Black 21 33
White 16 23
Sex
Male 18 23
Female 19 33
Education, years 10.4 0.8 9.8 0.5
Income
Lowb 19 39
High 18 17
Marital
Married 24 34
Single 13 22
Etiology uremia
Diabetes mellitus 2 14
Polycystic kidney 7 2
Other 28 40
Removed from therapy, expired 6(l)d 25(8)c
patients who were withdrawn primarily due to frequent epi-
sodes of peritonitis.
The reasons for withdrawal from CAPD and HHD varied
somewhat. In the CAPD group there were eight deaths, two
related to sepsis secondary to peritonitis and six related to
myocardial disease. Twelve were withdrawn because of fre-
quent episodes of peritonitis, two because of emotional unsuit-
ability to home dialysis, two were transplanted, and one patient
moved out of state. Among the HHD patients, one patient was
transferred to CAPD because of severe congestive heart failure
and died within 1 month of initiating CAPD; there were two
deaths related to myocardial infarction. One patient was with-
drawn because of emotional unsuitability for home dialysis, one
patient's assistant withdrew, and one patient had a return of
renal function (analgesic abuse nephropathy). If we reanalyze
the withdrawal rates from CAPD by removing the myocardial
deaths, the patients transferred, transplanted, and with the
return of renal function, we still note the withdrawal from
dialysis is greater for the CAPD patients (P < 0.05, x2 = 4.5).
Figure 1 details the improvement in the maintenance curve
when these patients are not included in the analysis.
Table 2 demonstrates that morbidity was greater in CAPD
patients than for HHD patients (7.5% 0.01 vs. 2.8% 0.01 P
< 0.025). Furthermore, morbidity (hospitalization rates) for
CAPD patients remaining on dialysis at the close of the review
was greater than the HITID patients (4.0% 0.01 CAPD vs.
1.9% 0.01 for HHD, P < 0.05). Among the HHD patients,
those withdrawn from dialysis were significantly older than
those remaining on dialysis (P < 0.05). The patients on HHD at
the close of the study were younger than the patients undergo-
ing CAPD therapy (P < 0.05).
Because the results with CAPD appeared inferior to those
with HHD, we explored subgroups of our CAPD population to
ascertain if any patient subgroup was associated with an
unfavorable outcome on dialysis and a particular set of demo-
graphic characteristics.
Table 3 provides selected information about the CAPD
patients grouped by frequency of peritonitis. Patients with more
frequent peritonitis were poorer and had less formal education
(P < 0.01, P <0.01, respectively). The group of patients with a
high infection rate, less than every 90 days on dialysis, had the
greatest withdrawal rate (P < 0.01). There were no differences
in the proportion of patients who required an assistant, marital
status, race, sex, and age.
There were 12 patients who remained on CAPD for less than
240 days and accounted for 18% of all days in the hospital
secondary to peritonitis. The average morbidity of this group
(hospitalization rate) was 13% 0.03 (9% secondary to perito-
nitis, 4% secondary to other medical diseases).
Of the 21 patients placed into CAPD with myocardial disease
there were four myocardial deaths; one patient was removed
because of peritonitis due to Candida albicans and died within 8
months of a myocardial event and one patient died secondary to
sepsis. Although this group is significantly older than the rest of
the patients undergoing CAPD (58 3 vs. 40 2 P <0.01),
there were no significant differences among demographic fea-
tures or between the incidence of peritonitis or hospitalization
rates.
To compare patients assigned to each of the two therapies,
we selected 16 patients from each group where age [43 4
(sEM) CAPD, 39 4 HFIDI, race (8 black, 8 white), sex (9
female, 7 male), income (10 < $10,000, 6 > $10,000), and
education (10.1 1.1 CAPD, 11.6 1.6 HHD) were matched.
Among these CAPD patients there were 4056 patient days on
home dialysis (average, 254 30) with 229 days spent in the
hospital, of which 79 days were due to peritonitis. Among the
HHD patients there were 5201 patient days on home dialysis
(average, 347 62) with 47 days spent in the hospital of which 3
were due to vascular access infection. Although we retrieved 16
matched patients, the CAPD group included eight with severe
myocardial disease. However, even excluding these eight pa-
tients, CAPD is associated with greater patient morbidity
(CAPD patient days at risk 1852, days in hospital 116, days in
hospital related to infection 47; HHD patient days at risk 3618,
days in hospital 15, days in hospital related to infection 3).
Table 1. Demographic features 1.00
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Fig. 1. Maintenance curves for patients undergoing CAPD and HHD.
The graph details the maintenance curve for CAPD with death due to
heart disease removed. Symbols: CAPD (N = 56); — — — — HHD
(N = 37); CAPD with death due to heart disease removed.
0 80 160 320 400 480 560 640 720 800
a Mean SEM.
b Low refers to income <$10,000 at start of dialysis; high refers to
income >$l0,000 at start of dialysis.
Two patients received a transplant; one patient was transferred out
of state.
Renal function returned in one patient.
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Table 3. I'atient characteristics and morbidity in relation to frequency of peritonitis
Number of patients
Income <$10,000
income >$ 10,000
Average time on dialysis. days
Age, years
Education. years
Creatinine clearance, mi/mm
(1.73 in2)
Morbidity due to peritonitis
Patients on dialysis at close of
study
Patients off dialysis at close of
study
Peritonitis less
than every 90
days
22
I 9
198 31'
48.6 3.5
7.6 0.9
2.4 + 0.4
0.06 0.01
8
l4
Peritonitis
between 90—180
13
12
days
354
47.8 4.8
11.0 0.9
0.7 0.3
0.06 i- 0.02
6
7
Peritonitis more
than every 180
days
21
8
13
253
44.9 3.6
11.3 0.6
3.5 0.6
0.002 0.001"
17
4
Table 4 details the overall mean blood chemistry, weights,
and blood pressure values for the two groups. Serum glucose (P
< 0.025), triglycerides (P <0.05), carbon dioxide content (P <
0.01), and hematocrit (P < 0.01) were greater in the CAPD
group. The overall mean values for serum creatinine (P <
0.025), phosphorus (P < 0.01), total serum proteins (P < 0.01),
and albumin (P < 0.01) were greater in the HHD group of
patients.
Among the CAPD patients the mean value for blood urea
nitrogen concentrations decreased significantly with time on
dialysis (P < 0.05), and plasma carbon dioxide content in-
creased (P < 0.05).
Among HHI) patients the mean value for serum proteins
increased significantly with time on dialysis (P < 0.025) and
serum cholesterol decreased (P < 0.025).
These changes in values, expressed as a rate of change of
slope were different for the two therapies with respect to blood
urea nitrogen (P < 0.05), serum creatinine (P < 0.05), and
plasma carbon dioxide content (P < 0.05).
Twenty-four hour creatinine clearance measurements were
obtained within 3 months of beginning home dialysis in 53
CAPD and 19 home hemodialysis patients. The corrected (1.73
m2) creatinine clearance of the HHD patients was significantly
greater than that of the CAPD patients (P < 0.05, 4.00 0.45,
2.68 0.40, respectively). This difference in residual renal
function remained even when the patients with polycystic
kidney disease were not included (P < 0.05), l'he corrected
creatinine clearance among CAPD patients (N = 14, 3.9
0.56) remaining on therapy at the close of the study was not
significantly different from the HHD group of patients (3.47
0.62, 4.00 0.45). Although the corrected creatinine clearance
among CAPD patients removed from dialysis was significantly
less than those patients remaining on dialysis (1.72 0.40, 3.47
0.62), we could not demonstrate a relationship between
Morbidity
Table 2.Morbidity unalysisa
Days on Days in
dialysis hospital
To/al Avg. Total
Hemodialysis (37) 15917 430" 241
CAPD (56) 14283 255 1004
30
Hemo on dialysis (31) 14849 479 173
CAPD on dialysis (31) 8193 264 414
Hemo off dialysis (6) 1068 178 68
20
CAPD off dialysis (25) 6090 244
37
The number in parentheses refers to the number of patients.
Mean SEM.
P < (1.05 CAPD on vs. HHD on.
"P < 0.05 CAPD vs. HHD.
Inf. Total
43 0.028"
577 0.075
10
43 0.0t9
167 0.04
(1 0.070
0063
410 0.114
Infection
0.007d
1.006
0.04
÷0.008
0.008c
0
0.075
0.0l I
a Frequency of peritonitis refers to infection rate and is defined in the text.
"P < 0.01 analysis of variance.
P < (1.01 x2.
Mean SEM.
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Table 4. Overall mean values and slopesa
CAPD HHD
Mean Slope Mean Slope(N = 56) (N = 56) (N = 37) (N = 34)
Glucose, mg/dI l44 —2.07 118 0.03
BUN, mgldl 58a 72 0.02
Creatinine, mgldl ll.6 0.05" 13.8 0.003
Carbon dioxide, mEqiliter 22e 0.12b,d 17 0.003
0.01
mgldl 4.8a —0.01 5.8 —0.0002
Total protein, gidI 6.2' —0.01 6.95 0.002"
Albumin, g/dl 3.2 —0.01 4.0 0.001
Cholesterol, mg/dl 206 —0.08 192 —0.13"
Triglycerides, mg/dl 209' 0.26 152 —0.24
Hematocrit, vol % 27' 0.01 24 —0.001
Weight, kg 60' —0.03 68 0.001
Mean blood pressure, mm Hg 83 0.15 92 0.001
'Mean = Mean SEM; The mean is derived from one mean value for each patient. The mean slopes for the CAPD patients were derived from 56
patients except for serum triglycerides (N = 45). The mean slopes for HHD were derived from 34 patients except for triglycerides (N = 31), and
weight (N = 27).
b P < 0.05 mean slope significantly different from 0.
P < 0.025 mean slope significantly different from 0.
d Mean slope of CAPD was significantly different from the mean slope of HHD P <0.05.
Overall mean value significantly different CAPD vs. HHD P < 0.01.
Overall mean value significantly different CAPD vs. HHD P < 0.025.
creatinine clearance and infection rate (Table 3). The length of
time the patients received chronic dialysis therapy prior to
home dialysis was not significantly different between the CAPD
and HHD patients (230 75 vs. 303 105, respectively).
Discussion
Patients that we select for either CAPD or HHD have similar
demographic characteristics. There were differences in etiolo-
gies of uremia between the two groups, but we do not feel that
this contributed to the striking differences noted in dialysis
modality failure. The drop-out rate and morbidity is much
greater with CAPD and is related largely to the frequency of
peritonitis. Our overall infection rate for this time period was
three episodes of peritonitis per patient year of dialysis (119
episodes, 14,283 days at risk), which represents a value not as
satisfactory as that reported by some programs but close to
other established programs 1$, 91. Among patients undergoing
CAPD the major features associated with withdrawal from
CAPD are low income and less education, however, not all
CAPD patients in this group did poorly.
The clinical importance of the differences noted in the mean
chemistry between the groups remains to be determined and
does not necessarily reflect the adequacy of dialysis. Obvious-
ly, the HHD patients are not dialyzed continuously which may
account for the differences in blood urea nitrogen, serum
creatinine, carbon dioxide content and phosphorus, patient
weight, and blood pressure. The greater serum proteins and
albumin among the HHD patients seems real. We cannot state
conclusively that this reflects improved overall nutrition. Our
data that evaluate changes over a period of time on dialysis for
weight do not support this contention.
CAPD is clearly favored for certain groups of patients. In our
experience patients who refuse blood transfusions, with dialy-
sis-related ascites [10], whose cardiovascular state precludes
hemodialysis and those lacking vascular access are best suited
for CAPD, particularly if they have home support. We do not
choose CAPD or HHD for elderly patients who do not have
back-up support at home. Our data illustrates that patients
unable to perform CAPD themselves may do well if a motivated
helper is found. Furthermore, since training time for CAPD is
brief relative to HHD, CAPD may be indicated for patients in
whom the period of dialysis is not expected to be prolonged, for
example, those awaiting transplantation.
The relatively high drop-out and hospitalization rate associat-
ed with the use of CAPD which we have reported must be
compared with recent reports suggesting CAPD is a valuable
adjunct to, or even a better form of, therapy than maintenance
hemodialysis [11, 12]. These reports describe a rather high
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treatment failure rate when compared to our results and those
reported by others for home hemodialysis [13—15]. Most of
these reports do not provide the same detail regarding the
frequency of hospitalizations over a long period of time nor do
these reports make any attempt to prospectively compare the
outcome of similar groups of patients assigned initially to either
CAPD or hemodialysis. Consequently, the reader cannot distin-
guish the relative merits of the two forms of therapy insofar as
patient outcome is concerned.
While we acknowledge that a prospectively randomized
comparison would probably provide an even clearer indication
of the relative merits of the two forms of therapy, the present
investigation did collect enough demographic information al-
lowing us to select patients from each group who were similar in
respect to age, sex, education, and socio-economic status (as
reflected in family income). These features were chosen to
match the two subgroups because our data suggested that these
features appeared to be associated statistically with variable
rates of peritonitis and hospitalization. When these matched
groups were compared with respect to hospitalization, a sub-
stantial difference favoring HHJ) persisted; and the removal of
patients known to have heart disease before dialysis began did
not alter this difference.
Although these previous reports [9, II, 15] have not provided
this apparently important demographic data about their pa-
tients, our results leave open the possibility that, in fact, their
CAPI) patients do remarkably well and that they might he more
similar, soeio-economically, to our low peritonitis group. If this
is true, there may be less difference between their results and
ours. Further studies will he necessary to clarify this point.
However, there presently is no direct evidence showing that
healthy patients otherwise able to perform HHD may be
maintained with less morbidity for a prolonged period utilizing
CAPD. Therefore we suggest that HHD is the home method of
choice for patients able to proceed with this technique. Excel-
lent results may he obtained with CAPD patients, hut careful
patient selection is necessary. To fully evaluate the two thera-
pies a randomized prospective trial must be performed.
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